Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chubb
Harvard Business School
Fish and Richardson
Citi
Johnson and Johnson
US Department of Justice
Colorcon
US Army
Julphar

Generated: August 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202489

« Back to Dashboard
NDA 202489 describes TINIDAZOLE, which is a drug marketed by Edenbridge Pharms, Novel Labs Inc, West-ward Pharms Int, and Unique Pharm Labs, and is included in four NDAs. It is available from six suppliers. Additional details are available on the TINIDAZOLE profile page.

The generic ingredient in TINIDAZOLE is tinidazole. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the tinidazole profile page.

Summary for NDA: 202489

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antiparasitics
Formulation / Manufacturing:see details

Pharmacology for NDA: 202489

Ingredient-typeNitroimidazoles

Suppliers and Packaging for NDA: 202489

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TINIDAZOLE
tinidazole
TABLET;ORAL 202489 ANDA Pack Pharmaceuticals, LLC 16571-214 16571-214-04 40 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-214-04)
TINIDAZOLE
tinidazole
TABLET;ORAL 202489 ANDA Pack Pharmaceuticals, LLC 16571-215 16571-215-06 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16571-215-06)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Oct 9, 2013TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Oct 9, 2013TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Colorcon
Queensland Health
Accenture
McKesson
Cantor Fitzgerald
Moodys
Dow
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot